It is for your kind information that AICTE has received a D.O. letter No. S-16030/13/2020-NAM dated 13/May/2021 from Ministry of Ayurveda, Yoga & Naturopathy Unani, Siddha, Sowa-Rigpa and Homeopathy (AYUSH) for compliance on the above cited subject. A copy of the letter is attached for your kind compliance. 

As per the attached letter, the Ayurvedic drug AYUSH-64 has been found useful in the treatment of asymptomatic, mild and moderate Covid-19 infection, through robust randomized clinical trials. This finding has emerged as a ray of hope for the patients of asymptomatic, mild and moderate Covid-19 infection.

AYUSH-64 is a polyherbal formulation developed by the Central Council for Research in Ayurvedic Sciences (CCRAS), Ministry of Ayush, initially for Malaria, in the year 1980. Now, the Ministry of Ayush-Council of Scientific and Industrial Research (CSIR) collaboration has completed a randomized multi-centre clinical trial to evaluate the safety and efficacy of AYUSH-64 in the management of Covid-19 In the clinical studies, it is found useful in the treatment of asymptomatic, mild and moderate Covid-19 infection, both as an adjunct to standard care and as a standalone. AYUSH-64 is manufactured by M/S Indian Medicines Pharmaceutical Corporation Limited (IMPCL), a PSU under the Ministry of Ayush, as well as by few other companies. The drug is easily available in the market.

The Ministry of Ayush feels that all Ministries/ Departments who have healthcare units or functionaries under them can contribute to taking the benefits of AYUSH -64 to the public. 

In this regard, AICTE requests your institute to kindly  disseminate   this information among all the students, faculty members & others to consider the use of AYUSH-64 in the asymptomatic, mild to moderate Covid-19 patients at Isolation Centres/Covid Care Care Centres /Covid Health Centres, at AYUSH Hospitals and dispensaries, and for patients in home isolation in organizations/units within their jurisdiction. This can be taken up in accordance with the standard Covid-19 instructions in force.

For more information, you may contact to below:
E-mail: dg-ccras@nic.in
Phone: 011-28524457

PFA:-https://drive.google.com/file/d/1lBJzbw07BXeuwkkz7bEhfrxsXUKlJtBj/view?usp=sharing  

With regards,
Manoj Singh,
Assistant Director (e-Governance),
All India Council for Technical Education,
Nelson Mandela Marg, Vasant Kunj, New Delhi-110070